Induction of glucose uptake and free fatty acid release by α-mangostin were accompanied by increasing mRNA expression of GLUT4 and leptin. These evidences propose that α-mangostin might be possible candidate for the effective management of obesity in future. This evidence concerns the gene SLC2A4 and obesity due to melanocortin 4 receptor deficiency.